…e demonstrated limited efficacy and significant side effects in solid tumors, primarily due to the expression of CD47 on healthy cells such …
solid tumors
This disease is selected. Its supporting articles are shown below.
Articles mentioning solid tumors
190 articles · page 10 of 16…ble success in the treatment of some malignancies, particularly leukemia. However, there are multiple factors that limit the durability …
…stently observed across multiple institutions for patients with melanoma. This now-approved strategy approaches 35% in recent studies fr…
…river alterations. Unfortunately, the majority of patients with NSCLC do not respond to ICI treatment or will eventually experience d…
…formance of chimeric antigen receptor T (CAR-T) cell therapy in solid tumors may provide a substantial advantage for patients with cancer. R…
…cokinetics (PK), and immunologic activity of MT-302 in advanced solid tumors with high rates of TROP2 expression. MT-302 was delivered off t…
…ckground Adoptive cell therapy (ACT) has had limited success in solid tumors, and patient access is a concern. Target antigen downregulation…
…, Chen S. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors. Cellular and Molecular Immunology. 2024;21(10):1089–1108.Wu X,…
…stic causes. In patients with signs and symptoms suggestive for myositis, a diagnostic muscular biopsy was performed.Results From Januar…
…6398730).Methods The GE-269-001 study enrolled 13 patients with solid tumors, and the GE-269-004 study enrolled six healthy volunteers. [ 18…
… B-cell lymphomas including 21 Diffuse Large B-Cell Lymphoma, 5 Burkitt’s Lymphoma, 5 Central Nervous System Lymphoma, 4 Mantle Cell Lymphoma. The…
…roenvironment (TME) is essential for advancing immunotherapy in solid tumors. While spatial transcriptomics provides detailed insights into …